<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The TAL1 locus on chromosome band 1p32 is rearranged in 15 to 29% of human <z:hpo ids='HP_0006727'>T-cell acute lymphoblastic leukemias</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALLs</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>These alterations consist of either a tald submicroscopic deletion (12-26% of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e>) or a t(1;14)(p32;q11) chromosomal translocation (3% of childhood <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Both types of alterations preferentially affect the 5' part of the TAL1 locus </plain></SENT>
<SENT sid="3" pm="."><plain>Their main consequence appears to be transcriptional activation of the TAL1 gene </plain></SENT>
<SENT sid="4" pm="."><plain>We have characterized two cases of t(1;14)(p32;q11) in ALL </plain></SENT>
<SENT sid="5" pm="."><plain>Both affect the TCR delta gene segments at 14q11 and the 5' part of the TAL1 locus at 1p32 </plain></SENT>
<SENT sid="6" pm="."><plain>The first case represented a 'classical' t(1;14), associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Its analysis indicates the use of a recombination signal-like sequence localized in the third exon of TAL1 in the translocation process </plain></SENT>
<SENT sid="8" pm="."><plain>In the other case, the rearrangement to the D delta region occurred 5' to the TAL1 transcription start sites </plain></SENT>
<SENT sid="9" pm="."><plain>This case exhibited a B-lymphoid immunophenotype thus suggesting that the putative oncogenicity of TAL1 activation is not restricted to T-cell <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
</text></document>